200 related articles for article (PubMed ID: 22035432)
21. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis.
Furst DE
Clin Exp Rheumatol; 2010; 28(3 Suppl 59):S5-12. PubMed ID: 20576219
[TBL] [Abstract][Full Text] [Related]
22. New therapeutic approaches for rheumatoid arthritis.
Abdelaty EM; Schumacher HR
Int J Clin Pract; 1999; 53(7):535-9. PubMed ID: 10692740
[TBL] [Abstract][Full Text] [Related]
23. Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis.
Semerano L; Assier E; Delavallée L; Boissier MC
Expert Opin Biol Ther; 2011 Apr; 11(4):545-50. PubMed ID: 21385114
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
Taniguchi A; Urano W; Tanaka E; Kamatani N
Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
[TBL] [Abstract][Full Text] [Related]
25. Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid Arthritis.
McBride S; Sarsour K; White LA; Nelson DR; Chawla AJ; Johnston JA
J Rheumatol; 2011 Oct; 38(10):2141-9. PubMed ID: 21844154
[TBL] [Abstract][Full Text] [Related]
26. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
28. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J;
Arthritis Rheum; 2012 Jan; 64(1):42-52. PubMed ID: 21898355
[TBL] [Abstract][Full Text] [Related]
29. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
Wolfe F; Michaud K
Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
[TBL] [Abstract][Full Text] [Related]
30. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid Arthritis - Anti-TNF.
Chaabo K; Kirkham B
Int Immunopharmacol; 2015 Aug; 27(2):180-4. PubMed ID: 25962818
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis.
Makrygiannakis D; Catrina AI
J Rheumatol; 2012 Apr; 39(4):679-85. PubMed ID: 22422498
[TBL] [Abstract][Full Text] [Related]
33. New therapies for rheumatoid arthritis.
Goldblatt F; Isenberg DA
Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842
[TBL] [Abstract][Full Text] [Related]
34. Current understanding of rheumatoid arthritis therapy.
Colmegna I; Ohata BR; Menard HA
Clin Pharmacol Ther; 2012 Apr; 91(4):607-20. PubMed ID: 22357455
[TBL] [Abstract][Full Text] [Related]
35. TNF as a Target of Inflammation in Rheumatoid Arthritis.
Yamanaka H
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):129-34. PubMed ID: 25772178
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of rheumatoid arthritis (RA) with anticytokines].
Feuchtenberger M; Kneitz C; Tony HP
MMW Fortschr Med; 2006 Oct; 148(42):44-5, 47. PubMed ID: 17621799
[TBL] [Abstract][Full Text] [Related]
37. B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.
Pala O; Diaz A; Blomberg BB; Frasca D
Clin Ther; 2018 Jun; 40(6):1034-1045. PubMed ID: 29801753
[TBL] [Abstract][Full Text] [Related]
38. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review.
Davignon JL; Rauwel B; Degboé Y; Constantin A; Boyer JF; Kruglov A; Cantagrel A
Arthritis Res Ther; 2018 Oct; 20(1):229. PubMed ID: 30314507
[TBL] [Abstract][Full Text] [Related]
39. Rheumatology meets hepatology in 2012: a clinician's guideline for TNF inhibitors in hepatitis B/C virus carriers.
Jansen TL; Mulder CJ
Expert Opin Biol Ther; 2012 Apr; 12(4):391-3. PubMed ID: 22413822
[TBL] [Abstract][Full Text] [Related]
40. Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis.
Dimopoulou D; Dimitroulas T; Akriviadis E; Garyfallos A
Rheumatol Int; 2015 Nov; 35(11):1913-6. PubMed ID: 26411882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
